# CONDUENT Inc: financial statements, quarterly

CNDT · Nasdaq · CIK 1677703 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cndt.md) · [Financials](/companies/cndt/financials.md) · [Filings](/companies/cndt/filings.md) · [Insiders](/companies/cndt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cndt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [932](/filings/0001677703-24-000135.md) | [953 d](/filings/0001677703-26-000024.md) | [921](/filings/0001677703-25-000076.md) | [828](/filings/0001677703-25-000126.md) | [807](/filings/0001677703-25-000152.md) | [800 d](/filings/0001677703-26-000024.md) | [751](/filings/0001677703-26-000059.md) | [603](/filings/0001677703-26-000092.md) | [767](/filings/0001677703-25-000152.md) | [770 d](/filings/0001677703-26-000024.md) | [723](/filings/0001677703-26-000059.md) | [531](/filings/0001677703-26-000092.md) |
| Cost of revenue | $m | [724](/filings/0001677703-24-000135.md) | [740 d](/filings/0001677703-26-000024.md) | [735](/filings/0001677703-25-000076.md) | [677](/filings/0001677703-25-000126.md) | [656](/filings/0001677703-25-000152.md) | [662 d](/filings/0001677703-26-000024.md) | [618](/filings/0001677703-26-000059.md) | [489](/filings/0001677703-26-000092.md) | [631](/filings/0001677703-25-000152.md) | [624 d](/filings/0001677703-26-000024.md) | [587](/filings/0001677703-26-000059.md) | [435](/filings/0001677703-26-000092.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [2.0](/filings/0001677703-24-000135.md) | [2.0 d](/filings/0001677703-26-000024.md) | [2.0](/filings/0001677703-25-000076.md) | [1.0](/filings/0001677703-25-000126.md) | [1.0](/filings/0001677703-25-000152.md) | [2.0 d](/filings/0001677703-26-000024.md) | [1.0](/filings/0001677703-26-000059.md) | [1.0](/filings/0001677703-26-000092.md) | [1.0](/filings/0001677703-25-000152.md) | [1.0 d](/filings/0001677703-26-000024.md) | [1.0](/filings/0001677703-26-000059.md) | [0.0](/filings/0001677703-26-000092.md) |
| Selling, general and administrative | $m | [115](/filings/0001677703-24-000135.md) | [114 d](/filings/0001677703-26-000024.md) | [116](/filings/0001677703-25-000076.md) | [115](/filings/0001677703-25-000126.md) | [115](/filings/0001677703-25-000152.md) | [109 d](/filings/0001677703-26-000024.md) | [120](/filings/0001677703-26-000059.md) | [90.0](/filings/0001677703-26-000092.md) | [96.0](/filings/0001677703-25-000152.md) | [96.0 d](/filings/0001677703-26-000024.md) | [91.0](/filings/0001677703-26-000059.md) | [80.0](/filings/0001677703-26-000092.md) |
| Interest expense | $m | [28.0](/filings/0001677703-24-000135.md) | [29.0 d](/filings/0001677703-26-000024.md) | [27.0](/filings/0001677703-25-000076.md) | [19.0](/filings/0001677703-25-000126.md) | [16.0](/filings/0001677703-25-000152.md) | [13.0 d](/filings/0001677703-26-000024.md) | [12.0](/filings/0001677703-26-000059.md) | [12.0](/filings/0001677703-26-000092.md) | [12.0](/filings/0001677703-25-000152.md) | [12.0 d](/filings/0001677703-26-000024.md) | [12.0](/filings/0001677703-26-000059.md) | [13.0](/filings/0001677703-26-000092.md) |
| Income tax | $m | [(24.0)](/filings/0001677703-24-000135.md) | [(10.0) d](/filings/0001677703-26-000024.md) | [28.0](/filings/0001677703-25-000076.md) | [84.0](/filings/0001677703-25-000126.md) | [36.0](/filings/0001677703-25-000152.md) | [(70.0) d](/filings/0001677703-26-000024.md) | [(5.0)](/filings/0001677703-26-000059.md) | [(1.0)](/filings/0001677703-26-000092.md) | [8.0](/filings/0001677703-25-000152.md) | [5.0 d](/filings/0001677703-26-000024.md) | [6.0](/filings/0001677703-26-000059.md) | [12.0](/filings/0001677703-26-000092.md) |
| Net income | $m | [(289)](/filings/0001677703-24-000135.md) | [6.0 d](/filings/0001677703-25-000029.md) | [99.0](/filings/0001677703-25-000076.md) | [216](/filings/0001677703-25-000126.md) | [123](/filings/0001677703-25-000152.md) | [(12.0) d](/filings/0001677703-25-000029.md) | [(51.0)](/filings/0001677703-26-000059.md) | [(40.0)](/filings/0001677703-26-000092.md) | [(46.0)](/filings/0001677703-25-000152.md) | [(33.0) d](/filings/0001677703-26-000024.md) | [(33.0)](/filings/0001677703-26-000059.md) | [(116)](/filings/0001677703-26-000092.md) |
| Diluted EPS | $ per share | [(1.34)](/filings/0001677703-24-000135.md) | not reported | [0.46](/filings/0001677703-25-000076.md) | [1.07](/filings/0001677703-25-000126.md) | [0.72](/filings/0001677703-25-000152.md) | not reported | [(0.33)](/filings/0001677703-26-000059.md) | [(0.26)](/filings/0001677703-26-000092.md) | [(0.30)](/filings/0001677703-25-000152.md) | not reported | [(0.23)](/filings/0001677703-26-000059.md) | [(0.76)](/filings/0001677703-26-000092.md) |
| Basic EPS | $ per share | [(1.34)](/filings/0001677703-24-000135.md) | not reported | [0.46](/filings/0001677703-25-000076.md) | [1.10](/filings/0001677703-25-000126.md) | [0.75](/filings/0001677703-25-000152.md) | not reported | [(0.33)](/filings/0001677703-26-000059.md) | [(0.26)](/filings/0001677703-26-000092.md) | [(0.30)](/filings/0001677703-25-000152.md) | not reported | [(0.23)](/filings/0001677703-26-000059.md) | [(0.76)](/filings/0001677703-26-000092.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [451](/filings/0001677703-23-000065.md) | [498](/filings/0001677703-25-000029.md) | [415](/filings/0001677703-24-000080.md) | [300](/filings/0001677703-24-000116.md) | [393](/filings/0001677703-24-000135.md) | [366](/filings/0001677703-26-000024.md) | [277](/filings/0001677703-25-000076.md) | [275](/filings/0001677703-25-000126.md) | [248](/filings/0001677703-25-000152.md) | [233](/filings/0001677703-26-000092.md) | [228](/filings/0001677703-26-000059.md) | [228](/filings/0001677703-26-000092.md) |
| Current assets | $m | [1,535](/filings/0001677703-23-000065.md) | [1,655](/filings/0001677703-25-000029.md) | [1,589](/filings/0001677703-24-000080.md) | [1,352](/filings/0001677703-24-000116.md) | [1,445](/filings/0001677703-24-000135.md) | [1,252](/filings/0001677703-26-000024.md) | [1,185](/filings/0001677703-25-000076.md) | [1,147](/filings/0001677703-25-000126.md) | [1,154](/filings/0001677703-25-000152.md) | [1,204](/filings/0001677703-26-000092.md) | [1,088](/filings/0001677703-26-000059.md) | [1,097](/filings/0001677703-26-000092.md) |
| Total assets | $m | [3,146](/filings/0001677703-23-000065.md) | [3,162](/filings/0001677703-25-000029.md) | [3,058](/filings/0001677703-24-000080.md) | [2,780](/filings/0001677703-24-000116.md) | [2,841](/filings/0001677703-24-000135.md) | [2,599](/filings/0001677703-26-000024.md) | [2,532](/filings/0001677703-25-000076.md) | [2,488](/filings/0001677703-25-000126.md) | [2,500](/filings/0001677703-25-000152.md) | [2,397](/filings/0001677703-26-000092.md) | [2,393](/filings/0001677703-26-000059.md) | [2,245](/filings/0001677703-26-000092.md) |
| Current liabilities | $m | [805](/filings/0001677703-23-000065.md) | [868](/filings/0001677703-25-000029.md) | [849](/filings/0001677703-24-000080.md) | [819](/filings/0001677703-24-000116.md) | [827](/filings/0001677703-24-000135.md) | [744](/filings/0001677703-26-000024.md) | [723](/filings/0001677703-25-000076.md) | [697](/filings/0001677703-25-000126.md) | [702](/filings/0001677703-25-000152.md) | [728](/filings/0001677703-26-000092.md) | [685](/filings/0001677703-26-000059.md) | [707](/filings/0001677703-26-000092.md) |
| Total liabilities | $m | [2,384](/filings/0001677703-23-000065.md) | [2,387](/filings/0001677703-25-000029.md) | [2,211](/filings/0001677703-24-000080.md) | [1,883](/filings/0001677703-24-000116.md) | [1,818](/filings/0001677703-24-000135.md) | [1,614](/filings/0001677703-26-000024.md) | [1,586](/filings/0001677703-25-000076.md) | [1,569](/filings/0001677703-25-000126.md) | [1,641](/filings/0001677703-25-000152.md) | [1,570](/filings/0001677703-26-000092.md) | [1,610](/filings/0001677703-26-000059.md) | [1,577](/filings/0001677703-26-000092.md) |
| Current portion of debt | $m | [40.0](/filings/0001677703-23-000065.md) | [34.0](/filings/0001677703-25-000029.md) | [33.0](/filings/0001677703-24-000080.md) | [33.0](/filings/0001677703-24-000116.md) | [26.0](/filings/0001677703-24-000135.md) | [24.0](/filings/0001677703-26-000024.md) | [26.0](/filings/0001677703-25-000076.md) | [28.0](/filings/0001677703-25-000126.md) | [16.0](/filings/0001677703-25-000152.md) | [22.0](/filings/0001677703-26-000092.md) | [23.0](/filings/0001677703-26-000059.md) | [21.0](/filings/0001677703-26-000092.md) |
| Shareholders' equity | $m | [617](/filings/0001677703-23-000065.md) | [629](/filings/0001677703-25-000029.md) | [701](/filings/0001677703-24-000080.md) | [751](/filings/0001677703-24-000116.md) | [877](/filings/0001677703-24-000135.md) | [839](/filings/0001677703-26-000024.md) | [800](/filings/0001677703-25-000076.md) | [777](/filings/0001677703-25-000126.md) | [717](/filings/0001677703-25-000152.md) | [685](/filings/0001677703-26-000024.md) | [641](/filings/0001677703-26-000092.md) | [526](/filings/0001677703-26-000092.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(11.0) d](/filings/0001677703-24-000135.md) | [122 d](/filings/0001677703-26-000024.md) | [(37.0)](/filings/0001677703-25-000076.md) | [(41.0) d](/filings/0001677703-25-000126.md) | [(13.0) d](/filings/0001677703-25-000152.md) | [41.0 d](/filings/0001677703-26-000024.md) | [(58.0)](/filings/0001677703-26-000059.md) | [(15.0) d](/filings/0001677703-26-000092.md) | [(39.0) d](/filings/0001677703-25-000152.md) | [39.0 d](/filings/0001677703-26-000024.md) | [(8.0)](/filings/0001677703-26-000059.md) | [7.0 d](/filings/0001677703-26-000092.md) |
| Capital expenditure | $m | [13.0 d](/filings/0001677703-24-000135.md) | [18.0 d](/filings/0001677703-26-000024.md) | [13.0](/filings/0001677703-25-000076.md) | [18.0 d](/filings/0001677703-25-000126.md) | [8.0 d](/filings/0001677703-25-000152.md) | [(11.0) d](/filings/0001677703-26-000024.md) | [14.0](/filings/0001677703-26-000059.md) | [15.0 d](/filings/0001677703-26-000092.md) | [15.0 d](/filings/0001677703-25-000152.md) | [15.0 d](/filings/0001677703-26-000024.md) | [9.0](/filings/0001677703-26-000059.md) | [9.0 d](/filings/0001677703-26-000092.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [219](/filings/0001677703-23-000065.md) | [218](/filings/0001677703-24-000080.md) | [218](/filings/0001677703-24-000116.md) | [217](/filings/0001677703-24-000135.md) | [216](/filings/0001677703-25-000076.md) | [202](/filings/0001677703-25-000126.md) | [171](/filings/0001677703-25-000152.md) | [162](/filings/0001677703-26-000059.md) | [161](/filings/0001677703-26-000092.md) | [157](/filings/0001677703-25-000152.md) | [155](/filings/0001677703-26-000059.md) | [155](/filings/0001677703-26-000092.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 155,520,800 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0001677703-26-000092.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.